drugset / Trial / NCT00074230
Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Vaccines made from a person's dendritic cells and antigens may make the body build an immune response to kill tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy using autologous dendritic cells with antigens in treating patients who have stage IV cutaneous melanoma.
Timeline
- Start
- 2003-07
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous Dendritic Cells loaded with MAGE-A3, MelanA and Survivin | Cell therapy | — | Other |